Chemotherapeutic Agents Increase the Risk for Pulmonary Function Test Abnormalities in Patients With Multiple Myeloma

Case reports of pulmonary toxicity have been published regarding bortezomib, lenalidomide, and thalidomide but there are no published reports looking at the possible long-term pulmonary effects of these medications. This article describes a possible relationship between the administration of bortezo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bruce, Jarrod T., Tran, Jerry M., Phillips, Gary, Elder, Pat, Mastronarde, John G., Devine, Steven M., Hofmeister, Craig C., Wood, Karen L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3481157/
https://ncbi.nlm.nih.gov/pubmed/22986117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2012.06.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados